TLR7 AGONIST TRIFLUOROACETATE SALT AND CRYSTALLINE FORM B THEREOF, PREPARATION METHODS AND USES

The present invention relates to a trifluoroacetate salt of a TLR7 agonist 2-butoxy-7-(4-(pyrrolidin-1-ylmethyl)benzyl)-5H-pyrrolo[3,2-d]pyrimidin-4-amine (formula I), crystalline form В of the trifluoroacetate salt, methods for preparing the trifluoroacetate salt and crystalline form B, and uses of...

Full description

Saved in:
Bibliographic Details
Main Authors Zhao, Rui, Ding, Zhaozhong, Wang, Zheng, Yang, Ling, Hu, Yinghu, Zhou, Yilong, Sun, Fei
Format Patent
LanguageEnglish
Ukrainian
Published 27.04.2020
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to a trifluoroacetate salt of a TLR7 agonist 2-butoxy-7-(4-(pyrrolidin-1-ylmethyl)benzyl)-5H-pyrrolo[3,2-d]pyrimidin-4-amine (formula I), crystalline form В of the trifluoroacetate salt, methods for preparing the trifluoroacetate salt and crystalline form B, and uses of the trifluoroacetate salt and crystalline form B.
Bibliography:Application Number: UAA201809128